Dhivya R. Sudhan

机构：Southwestern Medical Center, The University of Texas Southwestern Medical Center · ORCID：0000-0003-1778-8917

发表论文 83 篇 · 总被引 2543 次 · h-index 17

代表论文

• Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion (2024 · Cancer Cell · 被引 51)
• Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer (2023 · Cancer Research · 被引 30)
• Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion (2024 · Cancer Cell · 被引 16)
• Abstract ND06: First disclosure of AZD8421, a highly selective CDK2 inhibitor to address resistance to CDK4/6 inhibitors in breast and CCNE1-high cancers (2024 · Cancer Research · 被引 9)
• Abstract PO2-19-10: CAPItello-292 Phase 3: An open-label, randomized study of capivasertib, fulvestrant, and investigator’s choice of CDK4/6 inhibitor (palbociclib or ribociclib) in HR+/HER2– advanced breast cancer (2024 · Cancer Research · 被引 6)
• CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer (2025 · Journal of Clinical Investigation · 被引 5)